Here’s how you can check allotment of Deepak Builders & Engineering 

Deepak Builders & Engineers opened its IPO on October 21 and closed on October 23. It raised a sum of Rs 260.04 crore. The company’s IPO price band ranged between Rs 192 to Rs 203 per equity share. The allotment of the shares is likely to be finalised on October 24. 

Here’s how you can check allotment: 

Step 1

Open a tab on any search engine. After that search Kfin Technologies.

Step 2

Open the website of Kfin Technologies and hover on the ‘Products’. Now, in the drop-down menu go to the investors section and click on the IPO allotment status or click on Kfin Technologies. 

Step 3

Fill in all your details – the company’s name and Application number/ Demat account/ or PAN number (any of the three). 

Step 4

Enter the captcha and hit the search button. 

Refund and Listing

The refunds will likely be initiated on October 25 and shares will also be credited in the D’mat accounts of the allotted investors on October 25. The listing on NSE and BSE is likely on October 28.

GMP

The shares of Deepak Builders & Engineering were trading at a premium of 25% to its issue price in the unofficial market. In a grey market, shares change hands illegally before listing on the bourses. Market participants keep track of GMP to take cues regarding listing day gains. 

Also ReadDeepak Builders and Engineers IPO fully subscribed within two hours on Day 1

About Deepak Builders & Engineering 

Deepak Builders & Engineers India Ltd. (DBEIL), is an integrated engineering and construction company, specializing in the execution and construction of administrative & institutional buildings, hospitals and medical colleges, industrial buildings, historical memorial complexes, stadium and sports complexes, residential complexes, and various developmental and other construction activity.

Expert’s Take on IPO

“At a higher price band, the company is demanding a P/E multiple of 15.7x (to its FY24 EPS of Rs 13), which is at a discount to its peer average. Recently, the company has improved its margins by effectively controlling costs. The majority of the company’s projects are government-related. Going forward, we believe the company has strong long-term growth potential, supported by government initiatives in the construction sector and the overall positive outlook for the industry.

 » Read More

Related Articles

JB Pharma is riding the CDMO Opportunity. Jefferies reiterates buy…

Jefferies has maintained a Buy on JB Pharma with a revised target price of Rs 2,310. The stock currently trades at Rs 1,714/share implying an 34% upside. This new target price is just a shade lower than the previous target price of Rs 2,340. According to Jefferies, an international brokerage house, the growth drivers are

Two banking stocks to watch ahead of the RBI Policy

By Kiran Jani Bank Nifty reached its all-time high of 54,467 in September 2024. Following this peak, the index experienced a correction, dipping to 47,844 in January 2025—a decline of 7.29%. Despite this pullback, Kotak Bank and ICICI Bank showed relative resilience, delivering returns of 1.61% and -4.20%, respectively, during the same period. Source: Investing.com

New Tax Regime: These deductions, exemptions still available for you

The Indian government introduced a new tax regime in 2020, offering lower tax rates while removing several exemptions and deductions available under the old system. Initially optional, this regime became the default in 2023, requiring taxpayers to opt out if they wished to continue under the old structure. Despite the removal of many benefits, certain

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

JB Pharma is riding the CDMO Opportunity. Jefferies reiterates buy…

Jefferies has maintained a Buy on JB Pharma with a revised target price of Rs 2,310. The stock currently trades at Rs 1,714/share implying an 34% upside. This new target price is just a shade lower than the previous target price of Rs 2,340. According to Jefferies, an international brokerage house, the growth drivers are

Two banking stocks to watch ahead of the RBI Policy

By Kiran Jani Bank Nifty reached its all-time high of 54,467 in September 2024. Following this peak, the index experienced a correction, dipping to 47,844 in January 2025—a decline of 7.29%. Despite this pullback, Kotak Bank and ICICI Bank showed relative resilience, delivering returns of 1.61% and -4.20%, respectively, during the same period. Source: Investing.com

New Tax Regime: These deductions, exemptions still available for you

The Indian government introduced a new tax regime in 2020, offering lower tax rates while removing several exemptions and deductions available under the old system. Initially optional, this regime became the default in 2023, requiring taxpayers to opt out if they wished to continue under the old structure. Despite the removal of many benefits, certain

Range bound session: Nifty ends above 23,600, Sensex holds 78,000 led by Adani Ports, Infosys

The stock markets faced a downturn on Thursday, with major indices closing in the red. The BSE Sensex dropped by 213.12 points or 0.27%, ending the day at 78,058.16, while the NSE Nifty 50 saw a decline of 70.15 points, down by 0.3%, and closed at 23,626.15. The Nifty Bank index also ended the day

IT stocks stable as Cognizant raises annual and quarterly revenue guidance

Shares of Indian IT companies are in the spotlight today after the Nasdaq-listed IT services major Cognizant Technology Solutions, reported its Q4 results that exceeded Wall Street expectations. The Nifty IT Index as well as individual tech counters like Infosys, Wipro, Tech Mahindra and HCL Tech are all in the green even as the markets